The Royal Pharmaceutical Society (RPS) said despite the "incredibly exciting age" we live in, the market is "not set up to incentivise the production of new types of medicines".
RPS chief scientist Professor Jayne Lawrence said: "The current crisis in antimicrobial resistance is in part due to the lack of new classes of antibiotics coming on the market.
"Antibiotics can cure infections in weeks, so the volume of sales of drugs is low. This doesn't allow the tens or even hundreds of millions required for research and development to be recouped.
"Unless we find a way to develop treatments that cure illnesses in months, rather than treat symptoms for years, we will not see the breakthroughs that both scientists and patients want."
More top news
A highly toxic chemical was used in the death of North Korean leader Kim Jong-un's half brother last week, tests have shown.
A new survey has highlighted the disconnect between people's views on the GB Olympic team and funding for grassroots sport.
National Crime Agency officers have arrested a British man in connection with bribery offences linked to international cricket spot-fixing.